Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2002 19
2003 20
2004 17
2005 26
2006 26
2007 26
2008 25
2009 39
2010 34
2011 39
2012 42
2013 26
2014 24
2015 32
2016 38
2017 38
2018 54
2019 58
2020 66
2021 46
2022 48
2023 35
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

703 results

Results by year

Filters applied: . Clear all
Page 1
Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures.
Zanwar S, Gertz MA, Muchtar E, Buadi FK, Kourelis T, Gonsalves W, Go RS, Hayman S, Kapoor P, Binder M, Cook J, Dingli D, Leung N, Lin Y, Warsame R, Fonder A, Hobbs M, Hwa YL, Kyle RA, Rajkumar SV, Kumar S, Dispenzieri A. Zanwar S, et al. Among authors: rajkumar sv. Leukemia. 2024 Apr 9. doi: 10.1038/s41375-024-02243-5. Online ahead of print. Leukemia. 2024. PMID: 38594348 No abstract available.
Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple Myeloma.
Peipert JD, Zhao F, Lee JW, Shen SE, Ip E, O'Connell N, Carlos RC, Graham N, Smith ML, Gareen IF, Raper PJ, Weiss M, Kumar SK, Rajkumar SV, Cella D, Gray R, Wagner LI. Peipert JD, et al. Among authors: rajkumar sv. JAMA Netw Open. 2024 Mar 4;7(3):e243854. doi: 10.1001/jamanetworkopen.2024.3854. JAMA Netw Open. 2024. PMID: 38536173 Free PMC article. Clinical Trial.
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide.
Goel U, Charalampous C, Kapoor P, Binder M, Buadi FK, Dingli D, Dispenzieri A, Fonder A, Gertz MA, Gonsalves WI, Hayman SR, Hobbs MA, Hwa YL, Kourelis T, Lacy MQ, Leung N, Lin Y, Warsame RM, Kyle RA, Rajkumar SV, Kumar SK. Goel U, et al. Among authors: rajkumar sv. Blood Cancer J. 2024 Mar 26;14(1):55. doi: 10.1038/s41408-024-01039-1. Blood Cancer J. 2024. PMID: 38531841 Free PMC article.
Mode of progression in smoldering multiple myeloma: a study of 406 patients.
Abdallah NH, Lakshman A, Kumar SK, Cook J, Binder M, Kapoor P, Dispenzieri A, Gertz MA, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Lin Y, Kourelis T, Warsame R, Bergsagel L, Rajkumar SV. Abdallah NH, et al. Among authors: rajkumar sv. Blood Cancer J. 2024 Jan 17;14(1):9. doi: 10.1038/s41408-024-00980-5. Blood Cancer J. 2024. PMID: 38228628 Free PMC article.
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma.
Goldman-Mazur S, Visram A, Rajkumar SV, Kapoor P, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Hayman SR, Dingli D, Kourelis T, Gonsalves W, Warsame R, Muchtar E, Leung N, Kyle RA, Kumar SK. Goldman-Mazur S, et al. Among authors: rajkumar sv. Clin Lymphoma Myeloma Leuk. 2024 Mar;24(3):e104-e111.e1. doi: 10.1016/j.clml.2023.11.008. Epub 2023 Nov 27. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38135634
Muscle and fat composition in patients with newly diagnosed multiple myeloma.
Abdallah NH, Nagayama H, Takahashi N, Gonsalves W, Fonder A, Dispenzieri A, Dingli D, Buadi FK, Lacy MQ, Hobbs M, Gertz MA, Binder M, Kapoor P, Warsame R, Hayman SR, Kourelis T, Hwa YL, Lin Y, Kyle RA, Rajkumar SV, Broski SM, Kumar SK. Abdallah NH, et al. Among authors: rajkumar sv. Blood Cancer J. 2023 Dec 12;13(1):185. doi: 10.1038/s41408-023-00934-3. Blood Cancer J. 2023. PMID: 38086801 Free PMC article.
703 results